Skip to main content
Signal8

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or the leptin receptor (LEPR), alongside its use in patients with Bardet-Biedl and Alström syndromes. Furthermore, the company is progressing setmelanotide (the active compound in IMCIVREE) through Phase II clinical trials. These studies are evaluating its potential for a broader spectrum of applications, including obesity caused by heterozygous POMC or LEPR deficiencies, steroid receptor coactivator 1 (SRC1) deficiency, SH2B1 deficiency, MC4 receptor deficiency, and obesity associated with Smith-Magenis syndrome, POMC epigenetic disorders, and other MC4R-related conditions. Rhythm Pharmaceuticals holds a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The firm, headquartered in Boston, Massachusetts, was established in 2008 and changed its name from Rhythm Metabolic, Inc. to Rhythm Pharmaceuticals, Inc. in October 2015.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

NASDAQ:RYTMHealthcare
-0.54%$92.57
AH$92.57+0.00%vs close
Mkt Cap$6.37B
Float64.39M
O/S68.85M
Vol
$ Vol
RVOL
Inst Own-
SI17.1%
Earnings
Dilution
Financials Summary
Revenue$189.76M
Net Income-$196.54M
Total Assets$480.2M
Free Cash Flow-$116.63M
Debt & Equity
Debt 1%
Equity 67%
Preferred 32%
Total Debt$3.99M
Total Equity$270.03M
Preferred Stock$130.96M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in RYTM's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$480.2M
Liabilities$210.17M
Accounts Receivable$26.08M
Accounts Payable$13.95M
Inventory$25.75M
PP&E (Net)$4.15M
Goodwill$0
Intangible Assets$5.32M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$189.76M$130.13M$77.43M$23.64M$3.15M$0$0$0$0$0$0$0$0$0
YoY Growth45.8%68.1%227.6%649.5%----------
Cost of Revenue$19.49M$13.37M$9.3M$2.13M$599K$690K$834K$442K$223K$144K$0$0$0$0
Gross Profit$170.26M$116.76M$68.13M$21.5M$2.56M-$690K-$834K-$442K-$223K-$144K$0$0$0$0
Gross Margin89.7%89.7%88.0%91.0%81.0%---------
Research and Development$167.34M$237.96M$134.95M$108.63M$104.13M$90.45M$109.45M$50.34M$22.89M$19.59M$7.15M$5.28M$18.02M$15.68M
Selling, General, and Administrative$194.94M$144.3M$117.53M$92.03M$68.49M$46.13M$36.55M$28.08M$9.52M$6.31M$3.42M$1.21M$3.43M$2.46M
Other$0$0$0$0$0-$690K-$834K$0$0$0$0$0$0$0
Total Operating Expenses$362.28M$382.26M$252.48M$200.66M$172.61M$135.88M$145.17M$78.42M$32.41M$25.91M$10.57M$6.49M$21.45M$18.14M
Operating Income (EBIT)-$192.02M-$265.5M-$184.36M-$179.16M-$170.06M-$136.57M-$146M-$78.42M-$32.41M-$25.91M-$10.57M-$6.49M-$21.45M-$18.14M
Operating Margin-101.2%-204.0%-238.1%-757.9%-5391.9%---------
Interest Expense$20.58M$20.6M$13.89M$5.2M$0$0$0$0$0$0$0$0$0$0
Interest Income$15.29M$14.71M$13.95M$4.03M$447K$2.58M$5.27M$4.35M$566K$33K$0$0$0$0
Other Income (Expense)-$4.03M$5.25M$243K-$1.96M$100.45M$2.58M$5.27M$4.35M-$1.3M$33K-$500K$0$17K$8K
Income Before Tax (EBT)-$196.04M-$260.26M-$184.11M-$181.12M-$69.61M-$134M-$140.73M-$74.06M-$33.71M-$25.87M-$11.07M-$6.49M-$21.43M-$18.13M
Income Tax Expense$497K$346K$564K$0$0$0$0$0$0$0$0$0$0$0
Net Income-$196.54M-$260.6M-$184.68M-$181.12M-$69.61M-$130.73M-$134.62M-$74.06M-$33.71M-$25.87M-$11.07M-$6.49M-$21.43M-$18.13M
Net Income Margin-103.6%-200.3%-238.5%-766.2%-2207.1%---------
Supplementary Data
EPS-3.11-4.34-3.20-3.51-1.37-2.96-3.70-2.39-1.26-1.55-1.09-0.64-0.43-0.36
Diluted EPS-3.11-4.34-3.20-3.51-1.37-2.96-3.70-2.39-1.26-1.55-1.09-0.64-0.43-0.36
Weighted Average OS64.98M60.99M57.67M52.12M49.60M44.13M36.42M31.00M26.73M16.73M10.20M10.20M50.27M50.27M
EBITDA-$174.12M-$238.09M-$168.46M-$174.25M-$68.45M-$135.88M-$145.17M-$77.97M-$32.19M-$25.76M-$500K$0-$21.41M-$18.12M
EBITDA Margin-91.8%-183.0%-217.6%-737.1%-2170.4%---------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$54.3M$89.14M$60.08M$127.68M$59.25M$100.85M$62.29M$49.54M$34.24M$6.54M$34.87M$152K$7.36M$11.77M
Short-Term Investments$334.65M$231.43M$215.76M$205.61M$235.61M$71.94M$230.16M$202.52M$113.85M$4M$0$0$10.4M$5.27M
Cash and Short-Term Investments$388.95M$320.56M$275.85M$333.29M$294.86M$172.79M$292.46M$252.06M$148.08M$10.54M$34.87M$152K$17.76M$17.04M
Accounts Receivable$26.08M$18.51M$14.87M$6.22M$1.02M$0$0$0$0$0$0$0$0$0
Inventory$25.75M$18.74M$8.62M$2.92M$111K$0$0$0$0$0$0$0$0$0
Other Current Assets$9.97M$8.8M$6.67M$7.42M$3.99M$3.05M$3.51M$1.34M$1.06M$216K$623K$42K$0$0
Total Current Assets$466.92M$374.2M$308.27M$354.24M$308.39M$181.67M$302.4M$258.69M$150.67M$11.18M$35.49M$194K$18.14M$18.86M
Long-Term Assets
Property, Plant & Equipment Net$4.15M$4.11M$2.12M$3.38M$4.33M$5M$5.72M$1.12M$840K$930K$17K$0$24K$44K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$5.32M$6.17M$7.03M$7.88M$4.66M$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$3.81M$7.79M$15.33M$16.98M$12.14M$403K$403K$401K$225K$234K$1.77M$0$23K$23K
Total Long-Term Assets$13.28M$18.07M$24.48M$28.25M$21.14M$5.41M$6.12M$1.52M$1.06M$1.16M$1.78M$0$47K$67K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$480.2M$392.27M$332.75M$382.48M$329.52M$187.07M$308.52M$260.21M$151.74M$12.34M$37.27M$194K$18.19M$18.92M
Liabilities
Current Liabilities
Accounts Payable$13.95M$12.33M$4.88M$4.8M$5.74M$4.9M$10.41M$7.64M$2.43M$1.9M$1.43M$535K$1.47M$2.25M
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$194K$1.29M$1.29M$1.43M$7M$0$0$0$0$0$0$0$0$0
Other Current Liabilities$11.37M$43.59M$5.41M$2.42M$800K$180K$377K$60K$101K$156K$249K$0$12K$23K
Total Current Liabilities$105.94M$115.52M$55.2M$39.81M$43.43M$17.99M$24.42M$13.58M$6.72M$4.73M$5.27M$552K$3.06M$2.5M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$100.89M$108.27M$107.29M$77.15M$0$0$0$372K$228K$311K$0$0$72.59M$52.7M
Total Long-Term Liabilities$104.23M$112.21M$107.78M$78.41M$1.95M$2.55M$3.09M$372K$228K$311K$0$0$72.59M$52.7M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$210.17M$227.72M$162.99M$118.22M$45.37M$20.55M$27.5M$13.95M$6.95M$5.04M$5.27M$552K$75.65M$55.21M
Stockholders' Equity
Preferred Stock$130.96M$142.82M$0$0$0$0$0$0$0$40M$40M$0$0$0
Common Stock$67K$61K$59K$56K$50K$44K$44K$34K$27K$10K$93K$93K$53K$3K
Retained Earnings-$1.35B-$1.16B-$894.74M-$710.06M-$528.94M-$459.33M-$325.33M-$184.6M-$110.25M-$76.54M-$50.67M-$39.6M-$58.44M-$37.01M
Comprehensive Income & Other-$796K-$39K$134K-$92K-$1K$49K$0$0$0-$144K$0$0$8K-$26K
Other Stockholders' Equity$1.62B$1.32B$1.06B$974.26M$813.04M$625.81M$606.31M$430.82M$255.01M$83.83M$82.58M$39.15M$925K$720K
Total Equity$270.03M$164.55M$169.76M$264.26M$284.15M$166.53M$281.02M$246.26M$144.79M$7.3M$32M-$358K-$57.46M-$36.28M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$480.2M$392.27M$332.75M$382.48M$329.52M$187.07M$308.52M$260.21M$151.74M$12.34M$37.27M$194K$18.19M$18.92M
Supplementary Data
Total Debt$3.99M$3.94M$1.26M$1.94M$2.55M$3.09M$3.56M$0$0$0$0$0$0$0
Net Debt-$50.31M-$85.2M-$58.82M-$125.73M-$56.7M-$97.77M-$58.74M-$49.54M-$34.24M-$6.54M-$34.87M-$152K-$7.36M-$11.77M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$196.54M-$260.6M-$184.68M-$181.12M-$69.61M-$134M-$140.73M-$74.06M-$33.71M-$25.87M-$11.07M-$6.49M-$21.43M-$18.13M
Depreciation & Amortization$1.34M$1.56M$1.76M$1.67M$1.16M$690K$834K$442K$223K$144K$10.57M$6.49M$20K$17K
Deferred Income Tax$0$0$0$0-$100M$0$0$0$1.86M$0$0$0$0$0
Stock-Based Compensation$66.82M$39.68M$32.55M$19.83M$20.8M$17.45M$11.88M$6.39M$2.28M$1.17M$298K$66K$127K$0
Changes in Working Capital:
  Accounts Receivable-$7.57M-$3.65M-$8.64M-$5.2M-$1.25M$0$0$0$0$0-$60K$0$0$0
  Inventory-$7.47M-$10.12M-$5.71M-$2.81M-$11K$0$0$0$0$0$0$0$0$0
  Accounts Payable$21.89M$21.92M$14.77M$1.54M$18.31M-$6.45M$10.51M$6.95M$1.95M$467K$3.84M$0-$780K$1.58M
  Other Working Capital-$7.82M$2.42M$4.38M-$13.26M-$15.15M$551K-$5.44M-$6.29M-$1.99M$863K-$1.46M-$801K$2.78M-$1.38M
Total Working Capital Change-$968K$10.57M$4.81M-$19.72M$1.9M-$5.89M$5.07M$667K-$39K$1.33M$2.38M-$801K$2M$201K
Other Non-Cash Items$13.68M$94.9M$9.4M$5.91M-$250K-$234K$203K$4.51M-$76K$11K-$9.15M-$6.77M$255K$82K
Net Cash from Operating-$115.67M-$113.88M-$136.16M-$173.43M-$146M-$121.98M-$122.75M-$62.06M-$29.46M-$23.22M-$6.98M-$7.51M-$19.16M-$17.83M
Investing Activities
Capital Expenditures-$953K$0-$47K-$4.28M-$5.43M-$214K-$3.38M-$722K-$133K-$1.06M-$17K$0$0$0
Acquisitions$0$0$0$4M$100M$0$24.59M$0$0$0$0$0$0$0
Purchases of Investments-$348.67M-$268.31M-$354.92M-$251.94M-$524.97M-$86.87M-$295.82M-$248.59M-$126.92M-$15.22M$0$0-$28.74M-$8.8M
Sales of Investments$252.47M$260.64M$354.97M$284.25M$361.25M$245.61M$271.24M$162.17M$17.01M$11.17M$0$0$23.61M$3.53M
Other Investing Activities-$40M-$40.5M-$5.67M-$4M$7M$0-$24.59M-$86.43M-$109.91M-$4.05M$0$0$0$0
Net Cash from Investing-$137.15M-$48.17M-$5.67M$28.03M-$62.16M$158.53M-$27.97M-$87.15M-$110.04M-$5.11M-$17K$0-$5.13M-$5.27M
Financing Activities
Debt Repaid-$12.9M------------
Common Stock Issuance$237.88M$195.24M$48.88M$131.11M$161.73M$0$161.35M$162.88M$125.66M$0$39.62M$0$0$43K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0-$3.97M$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$19.92M$12.87M$25.49M$82.72M$4.75M$2.01M$2.12M$1.81M$700K$0$2.09M$7.42M$0$0
Net Cash from Financing$217.96M$191.24M$74.37M$213.83M$166.48M$2.01M$163.47M$164.69M$167.2M$0$41.71M$7.42M$19.88M$22.44M
Forex Effect$87K$2K-$142K$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$34.78M$29.19M-$67.6M$68.43M-$41.68M$38.56M$12.75M$15.48M$27.7M-$28.33M$34.72M-$89K-$4.4M-$660K
Supplementary Data
Operating Cash Flow-$115.67M-$113.88M-$136.16M-$173.43M-$146M-$121.98M-$122.75M-$62.06M-$29.46M-$23.22M-$6.98M-$7.51M-$19.16M-$17.83M
Capital Expenditure-$953K$0-$47K-$4.28M-$5.43M-$214K-$3.38M-$722K-$133K-$1.06M-$17K$0$0$0
Free Cash Flow-$116.63M-$113.88M-$136.2M-$177.71M-$151.44M-$122.19M-$126.14M-$62.78M-$29.59M-$24.28M-$6.99M-$7.51M-$19.16M-$17.83M
Cash at Beginning$89.6M$60.41M$128M$59.58M$101.26M$62.7M$49.94M$34.46M$6.54M$34.87M$152K$241K$11.77M$12.43M
Cash at End$54.82M$89.6M$60.41M$128M$59.58M$101.26M$62.7M$49.94M$34.24M$6.54M$34.87M$152K$7.36M$11.77M